Antiviral combinations
US4758572A · kind A · utility
8Cited by
8References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 1987 |
| Grant date | Jul 19, 1988 |
| Priority date | — |
| Expiry date | Mar 5, 2007 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Synergistic combinations of nucleoside analogues, which are converted to viral DNA polymerase inhibitors through the action of at least one virus-induced enzyme, and thiosemicarbazone ribonucleotide reductase inhibitors are especially useful in combatting herpes virus infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.